• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于确定普通人群胰腺癌风险的简易临床评分系统。

A Simple Clinical Scoring System to Determine the Risk of Pancreatic Cancer in the General Population.

作者信息

Yoshimura Dai, Fukasawa Mitsuharu, Yoda Yoshioki, Ohtaka Masahiko, Ooka Tadao, Takano Shinichi, Kawakami Satoshi, Fukasawa Yoshimitsu, Kuratomi Natsuhiko, Harai Shota, Shimamura Naruki, Hasegawa Hiroyuki, Imagawa Naoto, Suzuki Yuichiro, Yoshida Takashi, Kobayashi Shoji, Sato Mitsuaki, Yamaguchi Tatsuya, Maekawa Shinya, Enomoto Nobuyuki

机构信息

Department of Gastroenterology, Faculty of Medicine, University of Yamanashi, Chuo 409-3898, Japan.

Department of Gastroenterology, Japan Community Health Care Organization Yamanashi Hospital, Kofu 400-0025, Japan.

出版信息

Diagnostics (Basel). 2024 Mar 20;14(6):651. doi: 10.3390/diagnostics14060651.

DOI:10.3390/diagnostics14060651
PMID:38535071
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10969429/
Abstract

This study aimed to develop and validate a simple scoring system to determine the high-risk group for pancreatic cancer (PC) in the asymptomatic general population. The scoring system was developed using data from PC cases and randomly selected non-PC cases undergoing annual medical checkups between 2008 and 2013. The performance of this score was validated for participants with medical checkups between 2014 and 2016. In the development set, 45 PC cases were diagnosed and 450 non-PC cases were identified. Multivariate analysis showed three changes in clinical data from 1 year before diagnosis as independent risk factors: ΔHbA1c ≥ 0.3%, ΔBMI ≤ -0.5, and ΔLDL ≤ -20 mg/dL. A simple scoring system, incorporating variables and abdominal ultrasound findings, was developed. In the validation set, 36 PC cases were diagnosed over a 3-year period from 32,877 participants. The AUROC curve of the scoring system was 0.925 (95%CI 0.877-0.973). The positive score of early-stage PC cases, including Stage 0 and I cases, was significantly higher than that of non-PC cases (80% vs. 6%, = 0.001). The simple scoring system effectively narrows down high-risk PC cases in the general population and provides a reasonable approach for early detection of PC.

摘要

本研究旨在开发并验证一种简单的评分系统,以确定无症状普通人群中胰腺癌(PC)的高危人群。该评分系统利用2008年至2013年间PC病例以及随机选取的接受年度体检的非PC病例的数据开发而成。该评分的性能在2014年至2016年间接受体检的参与者中得到验证。在开发组中,确诊了45例PC病例,识别出450例非PC病例。多变量分析显示,诊断前1年临床数据的3项变化为独立危险因素:糖化血红蛋白(HbA1c)变化值≥0.3%、体重指数(BMI)变化值≤ -0.5以及低密度脂蛋白(LDL)变化值≤ -20 mg/dL。开发了一种纳入变量和腹部超声检查结果的简单评分系统。在验证组中,从32,877名参与者中,在3年期间确诊了36例PC病例。该评分系统的受试者工作特征曲线下面积(AUROC)为0.925(95%置信区间0.877 - 0.973)。包括0期和I期病例在内的早期PC病例的阳性评分显著高于非PC病例(80%对6%,P = 0.001)。该简单评分系统有效地缩小了普通人群中PC高危病例的范围,并为PC的早期检测提供了一种合理的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f719/10969429/b8d728f9c5f7/diagnostics-14-00651-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f719/10969429/8e2d3e0af645/diagnostics-14-00651-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f719/10969429/8f506bb762eb/diagnostics-14-00651-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f719/10969429/b8d728f9c5f7/diagnostics-14-00651-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f719/10969429/8e2d3e0af645/diagnostics-14-00651-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f719/10969429/8f506bb762eb/diagnostics-14-00651-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f719/10969429/b8d728f9c5f7/diagnostics-14-00651-g003.jpg

相似文献

1
A Simple Clinical Scoring System to Determine the Risk of Pancreatic Cancer in the General Population.一种用于确定普通人群胰腺癌风险的简易临床评分系统。
Diagnostics (Basel). 2024 Mar 20;14(6):651. doi: 10.3390/diagnostics14060651.
2
Accurate prediction of pregnancy viability by means of a simple scoring system.通过一个简单的评分系统准确预测妊娠的活力。
Hum Reprod. 2013 Jan;28(1):68-76. doi: 10.1093/humrep/des352. Epub 2012 Oct 30.
3
A Novel Scoring System to Improve the Detection Efficiency of Pancreatic Cystic Lesions in the General Population.一种新型评分系统,提高普通人群胰腺囊性病变的检出效率。
Intern Med. 2023 Feb 1;62(3):335-344. doi: 10.2169/internalmedicine.9104-21. Epub 2022 Jul 14.
4
Model to Determine Risk of Pancreatic Cancer in Patients With New-Onset Diabetes.用于确定新发糖尿病患者罹患胰腺癌风险的模型。
Gastroenterology. 2018 Sep;155(3):730-739.e3. doi: 10.1053/j.gastro.2018.05.023. Epub 2018 Jun 11.
5
A Web-Based Prediction Model for Cancer-Specific Survival of Elderly Patients Undergoing Surgery With Prostate Cancer: A Population-Based Study.基于网络的前列腺癌老年手术患者癌症特异性生存预测模型:基于人群的研究。
Front Public Health. 2022 Jul 12;10:935521. doi: 10.3389/fpubh.2022.935521. eCollection 2022.
6
Development and validation of a risk score for predicting postoperative delirium after major abdominal surgery by incorporating preoperative risk factors and surgical Apgar score.通过纳入术前风险因素和手术阿普加评分来开发和验证预测腹部大手术后术后谵妄的风险评分。
J Clin Anesth. 2021 Dec;75:110408. doi: 10.1016/j.jclinane.2021.110408. Epub 2021 Jul 6.
7
Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial.普通人群卵巢癌筛查的死亡率影响、风险及益处:英国卵巢癌筛查协作试验(UKCTOCS)随机对照试验
Health Technol Assess. 2025 May;29(10):1-93. doi: 10.3310/BHBR5832.
8
A Social Program for the Early Detection of Pancreatic Cancer: The Kishiwada Katsuragi Project.一项用于早期检测胰腺癌的社会项目:岸和田桂木项目。
Oncology. 2017;93 Suppl 1:89-97. doi: 10.1159/000481239. Epub 2017 Dec 20.
9
External validation of models and simple scoring systems to predict miscarriage in intrauterine pregnancies of uncertain viability.对模型和简单评分系统进行外部验证,以预测不明存活能力的宫内妊娠流产。
Hum Reprod. 2013 Nov;28(11):2905-11. doi: 10.1093/humrep/det342. Epub 2013 Aug 26.
10
A New Scoring System for Predicting Mortality in Hematological Malignancies with Sepsis: A Derivation and Validation Study.一种用于预测合并脓毒症的血液系统恶性肿瘤患者死亡率的新评分系统:一项推导与验证研究。
Cancer Manag Res. 2023 Sep 29;15:1073-1083. doi: 10.2147/CMAR.S428930. eCollection 2023.

本文引用的文献

1
The American Cancer Society's Facts & Figures: 2020 Edition.美国癌症协会《2020年事实与数据》版
J Adv Pract Oncol. 2020 Mar;11(2):135-136. doi: 10.6004/jadpro.2020.11.2.1. Epub 2020 Mar 1.
2
Cancer Statistics, 2021.癌症统计数据,2021.
CA Cancer J Clin. 2021 Jan;71(1):7-33. doi: 10.3322/caac.21654. Epub 2021 Jan 12.
3
Endoscopic ultrasound findings and pathological features of pancreatic carcinoma in situ.胰腺原位癌的内镜超声表现及病理特征
Endosc Int Open. 2019 Apr;7(4):E585-E593. doi: 10.1055/a-0839-4312. Epub 2019 Apr 12.
4
Roles of ERCP in the Early Diagnosis of Pancreatic Cancer.内镜逆行胰胆管造影术在胰腺癌早期诊断中的作用
Diagnostics (Basel). 2019 Mar 7;9(1):30. doi: 10.3390/diagnostics9010030.
5
Phases of Metabolic and Soft Tissue Changes in Months Preceding a Diagnosis of Pancreatic Ductal Adenocarcinoma.在诊断胰腺导管腺癌前数月的代谢和软组织变化阶段。
Gastroenterology. 2019 May;156(6):1742-1752. doi: 10.1053/j.gastro.2019.01.039. Epub 2019 Jan 22.
6
Prediction model for pancreatic cancer risk in the general Japanese population.一般日本人群中胰腺癌风险的预测模型。
PLoS One. 2018 Sep 7;13(9):e0203386. doi: 10.1371/journal.pone.0203386. eCollection 2018.
7
Model to Determine Risk of Pancreatic Cancer in Patients With New-Onset Diabetes.用于确定新发糖尿病患者罹患胰腺癌风险的模型。
Gastroenterology. 2018 Sep;155(3):730-739.e3. doi: 10.1053/j.gastro.2018.05.023. Epub 2018 Jun 11.
8
Multicenter study of early pancreatic cancer in Japan.日本多中心早期胰腺癌研究。
Pancreatology. 2018 Jan;18(1):61-67. doi: 10.1016/j.pan.2017.11.007. Epub 2017 Nov 20.
9
A novel scoring system to analyze combined effect of lifestyle factors on pancreatic cancer risk: a retrospective case-control study.一种分析生活方式因素对胰腺癌风险综合影响的新评分系统:一项回顾性病例对照研究。
Sci Rep. 2017 Oct 20;7(1):13657. doi: 10.1038/s41598-017-13182-w.
10
The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study.肥胖、2型糖尿病和代谢因素在胰腺癌中的作用:一项孟德尔随机化研究
J Natl Cancer Inst. 2017 Sep 1;109(9). doi: 10.1093/jnci/djx012.